American Journal of Kidney Diseases

Slides:



Advertisements
Similar presentations
John W. Pickering, PhD, Matthew T. James, MD, PhD, FRCPC, Suetonia C
Advertisements

Eric P.F. Chow, David P. Wilson, Lei Zhang 
Jeremy R. Chapman, AC, FRCP, FRACP  American Journal of Kidney Diseases 
Urinary ammonia and long-term outcomes in chronic kidney disease
Regional Differences in the Associations Between Prescribed Dialysate Sodium Concentration and Interdialytic Weight Gain in the Dialysis Outcomes and.
Do higher-risk patients benefit from off-pump coronary artery bypass grafting? Evidence from an ecologic analysis of randomized trials  Oliver Kuss, PhD,
Independent Community House Hemodialysis as a Novel Dialysis Setting: An Observational Cohort Study  Mark R. Marshall, BHB, MBChB, FRACP, MPH (Hons),
Quiz Page March 2008 American Journal of Kidney Diseases
Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times
Volume 86, Issue 1, Pages (July 2014)
Risk of ESRD and Mortality in Kidney and Bladder Stone Formers
Vanessa Grubbs  American Journal of Kidney Diseases 
Impact of Comorbidities on Mortality in Managed Care Patients With CKD
Prolonged warm ischemia time is associated with graft failure and mortality after kidney transplantation  Karthik K. Tennankore, S. Joseph Kim, Ian P.J.
Association of Left Atrial Volume With Mortality Among ESRD Patients With Left Ventricular Hypertrophy Referred for Kidney Transplantation  Rajan K. Patel,
Patient and Graft Survival Following Kidney Transplantation in Recipients With Cystinosis: A Cohort Study  Rebecca A. Spicer, MBChB, Philip A. Clayton,
Quiz Page July 2009 American Journal of Kidney Diseases
Jayme E. Locke, MD, MPH  American Journal of Kidney Diseases 
Serum Potassium and Short-term Clinical Outcomes Among Hemodialysis Patients: Impact of the Long Interdialytic Interval  Steven M. Brunelli, MD, MSCE,
Evaluation of the Potential Living Kidney Donor
Prediction of ESRD and Death Among People With CKD: The Chronic Renal Impairment in Birmingham (CRIB) Prospective Cohort Study  Martin J. Landray, PhD,
Salt and Hypertension American Journal of Kidney Diseases
Perspectives of Transplant Physicians and Surgeons on Reimbursement, Compensation, and Incentives for Living Kidney Donors  Allison Tong, PhD, Jeremy.
Ioannis Koulouridis, MD, MS, Lori Lyn Price, MAS, Nicolaos E
Lifetime Incidence of CKD Stages 3-5 in the United States
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
American Journal of Kidney Diseases
Yousef Rezaei, MD  American Journal of Kidney Diseases 
Volume 136, Issue 1, Pages (January 2009)
David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD 
Evidence for a Bidirectional Relationship between Cytomegalovirus Replication and acute Graft-versus-Host Disease  Nathan Cantoni, Hans H. Hirsch, Nina.
Proteinuria and Other Urinary Biomarkers in Kidney Transplantation: Why Are We Still Waiting for Godot?  Bertram L. Kasiske, MD  American Journal of Kidney.
Volume 77, Issue 7, Pages (April 2010)
Stephen P. McDonald  Kidney International Supplements 
Andrew D. Howard, MD, Robin S. Howard, MA, Stuart L
Interdialytic Weight Gain: Trends, Predictors, and Associated Outcomes in the International Dialysis Outcomes and Practice Patterns Study (DOPPS)  Michelle.
CPR 1.2.: Evaluation of Anemia in CKD
Hematopoietic Engraftment in Recipients of Unrelated Donor Umbilical Cord Blood Is Affected by the CD34+ and CD8+ Cell Doses  Seitaro Terakura, Eiichi.
Simon W. Rabkin et al. JACEP 2017;3:
Christina L. Klein, MD, Daniel C. Brennan, MD, FACP 
The influence of retransplantation on survival for pediatric lung transplant recipients  Ryuichi Waseda, MD, PhD, Alberto Benazzo, MD, Konrad Hoetzenecker,
Quiz Page April 2008 American Journal of Kidney Diseases
Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney.
The Precision of Standardized Hospitalization, Readmission, and Mortality Ratios for Dialysis Facilities  Steven M. Brunelli, MD, MSCE, Adam G. Walker,
Dennis G. Moledina, MD, Mark A. Perazella, MD 
Daniel T. Lackland, DrPH, David J.P. Barker, MD, PhD 
Erratum American Journal of Kidney Diseases
Peter A. McCullough, MD, MPH, Christopher T. Chan, MD, Eric D
KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target    American.
Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies  Charuhas V. Thakar, MD  American Journal.
Comparative Superiority of ACE Inhibitors Over Angiotensin Receptor Blockers for People With CKD: Does It Matter?  Dimitris Mavridis, PhD  American Journal.
Trial Quality in Nephrology: How Are We Measuring Up?
American Journal of Kidney Diseases
Erratum American Journal of Kidney Diseases
Allocation of the Highest Quality Kidneys and Transplant Outcomes Under the New Kidney Allocation System  Supreet Sethi, Reiad Najjar, Alice Peng, James.
Achieving Fairness in Access to Kidney Transplant: A Work in Progress
Preemptive kidney transplantation is associated with survival benefits among pediatric patients with end-stage renal disease  Sandra Amaral, Blayne A.
Quiz Page June 2009 American Journal of Kidney Diseases
American Journal of Kidney Diseases
Volume 87, Issue 3, Pages (March 2015)
American Journal of Kidney Diseases
Quiz Page January 2010 American Journal of Kidney Diseases
Clinical Practice Recommendations For Peritoneal Dialysis Adequacy
Maristela Böhlke, PhD  American Journal of Kidney Diseases 
Clinical Practice Guidelines for Peritoneal Dialysis Adequacy
Quiz page December 2003 American Journal of Kidney Diseases
Muscle Relaxant Use Among Hemodialysis Patients: Prevalence, Clinical Indications, and Adverse Outcomes  Diana Mina, Kirsten L. Johansen, Charles E. McCulloch,
TMEscore is a prognostic biomarker and predicts immunotherapeutic benefit. TMEscore is a prognostic biomarker and predicts immunotherapeutic benefit. A,
Andrew R. Rezvani, Barry E. Storer, Katherine A. Guthrie, H
Catheter Type, Placement, and Insertion Techniques for Preventing Catheter-Related Infections in Maintenance Peritoneal Dialysis Patients: Summary of.
Presentation transcript:

American Journal of Kidney Diseases Association Between Weight Loss Before Deceased Donor Kidney Transplantation and Posttransplantation Outcomes  Meera Nair Harhay, Karthik Ranganna, Suzanne M. Boyle, Antonia M. Brown, Thalia Bajakian, Lissa B. Levin Mizrahi, Gary Xiao, Stephen Guy, Gregory Malat, Dorry L. Segev, David Reich, Mara McAdams-DeMarco  American Journal of Kidney Diseases  DOI: 10.1053/j.ajkd.2019.03.418 Copyright © 2019 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Box and whisker plots depict the distribution of absolute weight change (in kilograms) from listing to transplantation among deceased donor kidney transplant recipients in the United States by year. Black bars in the middle of white boxes indicate median values. Bottoms and tops of boxes represent interquartile ranges (IQRs), and tops and bottoms of whiskers represent values for weight change that extend from the boxes by no more than the IQR × 1.5. American Journal of Kidney Diseases DOI: (10.1053/j.ajkd.2019.03.418) Copyright © 2019 National Kidney Foundation, Inc. Terms and Conditions

Figure 2 Nonlinear associations between relative pretransplantation weight change and posttransplantation outcomes among US deceased donor kidney transplant recipients. Figure shows results of fractional polynomial methods to model the nonlinear unadjusted association of pretransplantation relative weight change, relative to no weight change, with (A) transplant hospitalization length of stay (LOS), (B) all-cause graft loss, and (C) posttransplantation mortality. Histograms in light gray display overall cohort distribution of pretransplantation relative weight change. Black lines indicates unadjusted estimates for each outcome of interest. Dark gray areas represent 95% confidence intervals (CIs). American Journal of Kidney Diseases DOI: (10.1053/j.ajkd.2019.03.418) Copyright © 2019 National Kidney Foundation, Inc. Terms and Conditions

Figure 3 Cumulative incidence curves for (A) all-cause graft loss and (B) mortality by relative pretransplantation weight change from listing to transplantation among US deceased donor kidney transplant recipients from 2004 to 2014. Log-rank P values for the contrasts between weight change categories were <0.001 for all-cause graft loss and posttransplantation mortality, respectively. At 5 years posttransplantation, all-cause graft loss occurred among 25% of recipients with <5% weight change and 5% to 9.9% weight gain, respectively, among 26% of recipients with 5% to 9.9% weight loss, among 27% of recipients with ≥10% weight gain, and among 28% of recipients with ≥10% weight loss. At 5 years posttransplantation, mortality occurred among 16% of recipients with weight gain of 5% to 9.9% and ≥10%, respectively; among 17% of recipients with <5% weight change and weight loss of 5% to 9.9%, respectively; and among 19% of recipients with weight loss ≥10%. American Journal of Kidney Diseases DOI: (10.1053/j.ajkd.2019.03.418) Copyright © 2019 National Kidney Foundation, Inc. Terms and Conditions